Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations inERBB2andERBB3-Reference-Cited by-同舟云学术

Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations inERBB2andERBB3

Published:2018-01-16 Issue:7 Volume:124 Page:1358-1373
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ross Jeffrey S.¹²,Fakih Marwan³,Ali Siraj M.¹,Elvin Julia A.¹,Schrock Alexa B.¹,Suh James¹,Vergilio Jo-Anne¹,Ramkissoon Shakti¹,Severson Eric¹,Daniel Sugganth¹,Fabrizio David¹,Frampton Garrett¹,Sun James¹,Miller Vincent A.¹,Stephens Philip J.¹,Gay Laurie M.¹^ORCID

Affiliation:

1. Foundation Medicine Inc; Cambridge Massachusetts

2. Department of Pathology; Albany Medical Center; Albany New York

3. Department of Medical Oncology and Therapeutics Research City of Hope; Duarte California

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference90 articles.

1. The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen;Schechter;Nature,1984

2. The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis;Moasser;Oncogene,2007

3. Oncogenic alterations in ERBB2/HER2 represent potential therapeutic targets across tumors from diverse anatomic sites of origin;Chmielecki;Oncologist,2015